Abstract
Childhood cancer survival rates in highly developed countries have risen remarkably over the past 50 years from <10 % to over 80 %. This has been achieved as a result of early and precise diagnosis, effective and targeted treatment, and adequate supportive care. This contrasts with the situation in low- and middle-income countries (LMICs) where overall survival rates are <20 %. In order to address this gross inequity and improve chances of survival of children with cancer, a number of twinning programs, linking pediatric oncology units in resource-rich countries with units in countries with limited resources, have been established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Guidelines adapted from St Jude: International Outreach Program—Guide to Establishing a Pediatric Oncology Twinning Program.
- 2.
Many different definitions are used in the literature. WHO [1] adopts a broader definition, encompassing general eHealth: telemedicine is “the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interest of advancing the health of individuals and their communities.”
References
Wilimas JA, Ribeiro RC. Pediatric hematology-oncology outreach for developing countries. Hematol Oncol Clin North Am. 2001;15(4):775–87, x.
Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, Ribeiro RC. Childhood cancer epidemiology in low-income countries. Cancer. 2008;112(3):461–72.
Magrath I, et al. Pediatric oncology in less developed countries. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott; 1993. p. 1225–51.
Ribeiro RC, Pui CH. Saving the children–improving childhood cancer treatment in developing countries. N Engl J Med. 2005;352(21):2158–60.
Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer. 2008;44:2388–96.
Wagner HP, Antic V. The problem of pediatric malignancies in the developing world. Ann N Y Acad Sci. 1997;824:193–204.
Masera G, Baez F, Biondi A, et al. Bridging the childhood cancer mortality gap between economically developed and low income countries: lessons from the MISPHO experience. In: Tannenberg S, Cavalli F, Pannuti F, editors. Cancer in developing countries. The great challenge for oncology in the 21st century. Muenchen: Zuckschwerdt; 2004. p. 42–60.
Wagner H. Alliances in pediatric oncology: where do we go from here? Med Pediatr Oncol. 2001;36(2):310–1.
The Montevideo Document. SIOP News. 1997;17:32.
Baez F, Ocampo E, Conter V, et al. Treatment of childhood Hodgkin’s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol. 1997;8:247–50.
Baez F, Pillon M, Manfredini L, et al. Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua. Pediatr Blood Cancer. 2008;50:148–52.
Baez F, Fossati Bellani F, Ocampo E, et al. Treatment of childhood Wilms’ tumor without radiotherapy in Nicaragua. Ann Oncol. 2002;13:944–8.
Masera G, Baez Lacayo F, Malta Corea A, et al. Pediatric oncology in developing countries: a cooperative program in Nicaragua. Ann Oncol. 1993;4:37–40.
SIOP. 43rd Congress of the International Society of Paediatric Oncology (SIOP) 2011, Auckland, New Zealand, 28th–30th October 2011. Abstracts Pediatr Blood Cancer. 2011;57(5):705–897. doi:10.1002/pbc.23299.
Masera G, Baez F, et al. North–south twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet. 1998;352(9144):1923–6.
D’Angio GJ. The La Mascota project. J Pediatr Hematol Oncol. 2009;31(10):709.
Masera G. Bridging the childhood cancer mortality gap between economically developed and low-income countries. J Pediatr Hematol Oncol. 2009;31(10):710–2.
Edefonti A, Montini G, Castellon M; for the Nicaraguan Network of Pediatric Nephrology—NINEPEN. Comprehensive cooperative project for children with renal disease in Nicaragua. Clin Nephrol. 2010;74 Suppl. 1:S119–25.
Sala A, Barr RD, Masera G, MISPHO Consortium. A survey of resources and activities in the MISPHO family of institutions in Latin America: a comparison of two eras. Pediatr Blood Cancer. 2004;43(7):758–64.
Howard SC, Marinoni M, Castillo L, Bonilla M, Tognoni G, Luna-Fineman S, Antillon F, Valsecchi MG, Pui CH, Ribeiro RC, Sala A, Barr RD, Masera G, MISPHO Consortium Writing Committee. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer. 2007;48(3):364–9.
Howard SC, Ortiz R, Baez LF, Cabanas R, Barrantes J, Fu L, Peña A, Samudio A, Vizcaino M, Rodríguez-Galindo C, Barr RD, Conter V, Biondi A, Masera G, MISPHO Consortium Writing Committee. Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—part I. Pediatr Blood Cancer. 2007;48(4):486–90.
Valsecchi MG, Tognoni G, Bonilla M, Moreno N, Baez F, Pacheco C, Hernandez AP, Antillon-Klussmann F, Machin S, Cabanas R, Navarrete M, Nieves R, De Lorenzo P, Masera G, Monza’s International School of Paediatric Hematology-Oncology. Clinical epidemiology of childhood cancer in Central America and Caribbean countries. Ann Oncol. 2004;15(4):680–5.
Rohatiner A. Keynote comment: not just an exercise in solidarity. Lancet Oncol. 2005;6(11):818–9.
Antillon F, Baez FL, Barr R, Barrantes Zamorra JC, Carrasco LF, Moreno B, Bonilla MM, Tognoni G, Valsecch MG, Howard S, Ribeiro RC, Masera G. AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer. 2005;45(2):107–10.
Quintana Y, Nambayan A, Ribeiro R, et al. Cure4Kids—building online learning and collaboration networks. AMIA Annu Symp Proc. 2003;2003:978.
Israëls T, Chirambo C, Caron H, de Kraker J, Molyneux E, Reis R. The guardians’ perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer. 2008;51:639–42.
Hesseling PB, Broadhead R, Molyneux E, Borgstein E, Schneider JW, Louw M, Mansvelt EP, Wessels G. Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol. 2003;41:532–40.
Mostert S, Sitaresmi M, Gundy C. PK020 influence of socioeconomic status on childhood acute lymphoblastic leukaemia treatment in Indonesia [abstract]. Pediatr Blood Cancer. 2006;47:489.
Hunger SP, Sung L, Howard SC. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: a proposal. Pediatr Blood Cancer. 2009;52(5):559–65. doi:10.1002/pbc.21889.
Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49(7):941–6.
Sitaresmi MN, Mostert S, Schook RM, Sutaryo, Veerman AJ. Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psychooncology. 2010;19(4):361–7. doi:10.1002/pon.1578.
Spinetta JJ, Masera G, Eden T, et al. Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP Working Committee on Psychosocial Issues in Paediatric Oncology. Med Pediatr Oncol. 2002;38:114–7.
World Health Organization, Telemedicine: opportunities and developments in member states; report on the Second Survey on eHealth, 2010 (Global Observatory for eHealth Series 2). Available from http://www.who.int/goe/publications/goe_telemedicine_2010.pdf
ITU. Measuring the information society; 2012. Available from http://www.itu.int/ITU-D/ict/publications/idi/material/2012/MIS2012_without_Annex_4.pdf
Bellina L, Missoni E. Mobile cell-phones (M-phones) in telemicroscopy: increasing connectivity of isolated laboratories. Diagn Pathol. 2009;4:19.
Bellina L, Missoni E. M-learning: mobile phones’ appropriateness and potential for the training of laboratory technicians in limited-resource settings. Health Technol. 2011;1:93–97
Acknowledgments
We would like to thank the following for their contribution to the project “La Mascota”: Fondazione CARIPLO, Comitato Maria Letizia Verga, Fondazione Tettamanti, Fondazione Zegna, AMCA (Bellinzona, Switzerland), CONANCA and MAPANICA (Nicaragua), the HMJR “La Mascota” Hospital (Managua), St. Jude Children’s Research Hospital (SJCRH, Memphis, USA), and the Pediatric Oncology Group of Ontario (POGO).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Conter, V., Polillo, R., Brivio, E., Faravelli, A., Masera, G. (2014). The Role of Twinning Programs and Telemedicine in Pediatric Oncology. In: Stefan, D., Rodriguez-Galindo, C. (eds) Pediatric Hematology-Oncology in Countries with Limited Resources. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3891-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3891-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3890-8
Online ISBN: 978-1-4614-3891-5
eBook Packages: MedicineMedicine (R0)